|
HER2,trastuzumab deruxtecan± pertuzumab Clinical Trials
1 actively recruiting trial
Also known as: Cohort9(HER2-positive, DS-8201 ± pertuzumab)
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.